Visible-light-activated non-toxic photodynamic antimicrobial technology for household surface disinfection

Overview

Biofilms on household surfaces create protected environments where pathogenic bacteria and viruses thrive, making them far more difficult to eliminate than free-floating microorganisms. This technology addresses that challenge with a visible-light-activated, cationic molecule that generates transient reactive oxygen species—specifically singlet oxygen—to deactivate microbes on contact. By covalently attaching the molecule to short polymer chains, the system minimizes bioavailability while encouraging trace residues that continue working after initial application. The result is a dual-action disinfectant that delivers both immediate kill and lasting surface protection, with low inherent toxicity when not exposed to light.

The light-activated mechanism means the active ingredient remains low hazard in darkness and only becomes antimicrobial when exposed to ambient visible light, offering a differentiated safety and efficacy profile compared to conventional chemical disinfectants.

Technical specifications

Mechanism of action:

• Cationic, singlet oxygen-generating molecule activated by visible light at ambient intensity
• Kill mechanism involves transient generation of reactive oxygen species; molecule itself is low hazard in darkness
• Covalent attachment to short polymer chains (e.g., PEG-150 distearate) minimizes bioavailability and promotes surface retention

Validated performance:

• Effective biofilm inhibition and eradication of P. aeruginosa over 24 hours under visible light
• Demonstrated activity against S. aureus biofilms and Influenza A on woven filter material
• Minimum Biofilm Inhibition and Eradication Concentration (MBIC/MBEC) testing per ASTM E2799-17
• Effective both in nutrient broth solution and on coated surface coupons, supporting both immediate and residual activity claims

Formulation considerations:

• Designed for crosslinking onto polymers already present in consumer disinfectant bases to preserve user experience attributes such as viscosity and feel
• Future validation will include serial dilution studies in nutrient-rich environments and “real world” challenge conditions

Technology readiness level

The core photodynamic antimicrobial has been validated in laboratory studies demonstrating biofilm inhibition and eradication of P. aeruginosa and S. aureus, as well as antiviral activity against Influenza A. Current work focuses on formulation integration—specifically crosslinking the active molecule onto PEG-150 distearate or similar polymers present in commercial disinfectant products—to enable incorporation without significant reformulation. Next-stage validation will establish efficacy in nutrient-rich environments and on dried surface coupons simulating real-world cleaning conditions, with “real world” challenge testing planned. The technology is at an early-to-mid stage of development, with proven molecular efficacy and ongoing work toward commercial formulation readiness.